Cancer Vaccines
New research in the area of cancer vaccines detailed
Published in Vaccine Weekly, April 26th, 2006
Study 1: Scientists can selectively target antitumor immune responses with engineered live-attenuated Listeria monocytogenes.
"Improved immunization and ex vivo T-cell culture strategies can generate larger numbers and more potent tumor-specific effector cells than previously possible. Nonetheless, the capacity of these cells to eliminate established tumors is limited by their ability to efficiently enter tumor-bearing organs and mediate their effector function. In the current study, we show that the administration of an engineered organ-homing...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2006-04-26)
More Articles from Vaccine Weekly
- Anthrax Vaccine
N-fragment of edema factor is candidate antigen for anthrax vaccine - Avian Influenza Vaccine
Adenovirus-based vaccine protects against lethal H5N1 avian influenza - Helicobacter Vaccine
CTA1-DD adjuvant enhances immunity against Helicobacter pylori infection - Rotavirus Vaccine
Rectally delivered vaccine protects mice against rotavirus infection - SARS Vaccine
Inactivated Vero-cell SARS vaccine is safe and effective in monkeys - Allergy & Immunology
Recombinant allergens, hypoallergenic derivatives are potential type I allergy therapy - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
